Martingale Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80,371
| Closed | -$211K | – | 846 |
|
|
2025
Q1 | $211K | Hold |
80,371
| – | – | 0.01% | 737 |
|
|
2024
Q4 | $331K | Buy |
80,371
+2,700
| +3% | +$11.1K | 0.01% | 674 |
|
|
2024
Q3 | $550K | Buy |
77,671
+700
| +0.9% | +$4.96K | 0.01% | 609 |
|
|
2024
Q2 | $502K | Buy |
76,971
+19,145
| +33% | +$125K | 0.01% | 596 |
|
|
2024
Q1 | $480K | Buy |
57,826
+11,130
| +24% | +$92.4K | 0.01% | 626 |
|
|
2023
Q4 | $514K | Buy |
46,696
+17,330
| +59% | +$191K | 0.01% | 610 |
|
|
2023
Q3 | $247K | Buy |
+29,366
| New | +$247K | 0.01% | 719 |
|